Literature DB >> 25871624

Heart failure prognosis: comorbidities matter.

Raya E Kheirbek1, Farrokh Alemi, Ross Fletcher.   

Abstract

BACKGROUND: Prior risk prediction models have included a selective group of broad comorbidities in scoring prognosis of heart failure (HF) patients.
OBJECTIVE: We examined whether scoring a comprehensive set of comorbidities separately, could improve the performance and accuracy of predicting HF prognosis.
METHODS: This is a cross-validated, longitudinal, retrospective, observational study. Data were collected on 602,050 unique HF patients, who received care through the Veterans Administration (VA) between October 1, 2006 and September 31, 2011. The dependent variable was mortality in six months. The independent variables were all International Classification of Disease (ICD) comorbidities, without grouping into broad disease categories.
RESULTS: The area under the receiver-operating curve (AROC) for the multimorbidity (MM) index was 0.784 (95% confidence interval [CI]: 0.781-0.786). The MM index was significantly (alpha <0.05) more accurate than the Quan variant of the Charlson Index (AROC=0.656), the comorbidity categories within the Care Assessment of Need (CAN) Index (AROC=0.677), the von Walraven variant of the Elixhauser Index (AROC=0.639), chronological age (AROC=0.649), or ejection fraction (EF) (AROC=0.533).
CONCLUSION: Inclusion of additional comorbidities improves the accuracy of HF prognostic indices. Future studies are needed to drive HF prognostic indices with the MM index as a component.

Entities:  

Mesh:

Year:  2015        PMID: 25871624     DOI: 10.1089/jpm.2014.0365

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  3 in total

1.  Emerging approaches to multiple chronic condition assessment.

Authors:  Jerry Suls; Marcel E Salive; Siran M Koroukian; Farrokh Alemi; Jeffrey H Silber; Gabi Kastenmüller; Carrie N Klabunde
Journal:  J Am Geriatr Soc       Date:  2022-06-14       Impact factor: 7.538

2.  National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator.

Authors:  Charlotta Lindvall; Neal A Chatterjee; Yuchiao Chang; Betty Chernack; Vicki A Jackson; Jagmeet P Singh; Joshua P Metlay
Journal:  Circulation       Date:  2015-12-03       Impact factor: 29.690

3.  The Multimorbidity Index: A Tool for Assessing the Prognosis of Patients from Their History of Illness.

Authors:  Farrokh Alemi; Cari R Levy; Raya E Kheirbek
Journal:  EGEMS (Wash DC)       Date:  2016-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.